The action of phosphocreatine and fructose 1,6-diphosphate on blood in vitro.
Blood in vitro has been used to evaluate the effects of phosphocreatine and fructose 1,6-diphosphate on the adenylate cycle. These compounds, following different metabolic pathways, increased the ATP concentration, phosphocreatine through a direct action on the adenylic phosphate cycle and fructose 1,6-diphosphate mainly by it glycolytic effect.
D000244:Adenosine Diphosphate / Q000097:blood; D000249:Adenosine Monophosphate / Q000097:blood; D000255:Adenosine Triphosphate / Q000097:blood; D001769:Blood / Q000187:drug effects*; D005636:Fructosephosphates / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D010725:Phosphocreatine / Q000494:pharmacology; D013997:Time Factors
D005636:Fructosephosphates; D010725:Phosphocreatine; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate